Skip to main content
OpenTrials
Completed

NCT Number: NCT01897753

Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age

The purpose of this protocol is to retrospectively study the influence of age at start of growth hormone (GH) treatment on height gain in children born small for gestational age (SGA).

Completed

Looking for future studies?

Notify Me

Key information

Age range

4 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

H. Germans Trias i Pujol, Badalona, Barcelona, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • SGA children.
  • Treated with GH at least 36 months.

Exclusion criteria

  • Patients treated with GH for other indications (not SGA).

Treatment and study plan

growth hormone

Drug

36 months

Primary outcomes

  1. height SDS

    Time frame: 36 months

    height SDS of SGA children after 36 months of treatment

Secondary outcomes

  1. height increase

    Time frame: 36 months

  2. Change from Baseline in Lipid Parameters at Month X

    Time frame: 36 months

    Mean Total Cholesterol (TC), Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), and Triglyceride blood concentrations.

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

Retrospective Study Of The Influence Of Age At Start Of Growth Hormone (Gh) Treatment On Height Gain In Children Born Small for Gestational Age (SGA)

Acronym: GH-RAST

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Jul 12, 2013
Registry last updated
Jan 20, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.